inhaled nebulized or aerosolized glutathione for Holistic Detox, Medication Cessation 2023-06 JAMPDD Vol 36, Issue

The NEDA approach continues to evolve, as MS experts have recognized the need to include measures of disease progression such as brain atrophy, and to develop ways to precisely measure outcomes in clinical practice

10.1016/j.therap.2019.01.010 69 MessmerM

JPEN J Parenter Enteral Nutr 23, S59S61 (1999)

the compounds of formula (I) described herein can be administered alone or in combination with adjuvants that enhance stability of the compounds of formula (I), alone or in combination with one or more therapeutic agents, facilitate administration of pharmaceutical compositions containing them in certain embodiments, provide increased dissolution or dispersion, increase inhibitory activity, provide adjunct therapy, and the like, including other active ingredients

Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis